- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT05743153
Viabilidad de un programa de intervención multimodal para optimizar los resultados del tratamiento en colitis ulcerosa (OPTIMIZE-UC)
OPTIMIZE-UC: viabilidad de un programa de intervención multimodal para optimizar los resultados del tratamiento en colitis ulcerosa: un estudio piloto prospectivo
This is a prospective, interventional pilot study to assess the feasibility and optimal timing of a multimodal intervention program in Ulcerative Colitis (UC) patients with active disease as well as in patients in remission. Secondly, to demonstrate the effects of a multimodal intervention program on individual patients level and therapy outcomes.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Rationale: Despite considerable advances in the knowledge of UC, and a variation of treatment options, UC still impacts patients' ability to lead a normal life. Clearly, there is an unmet need to improve treatment outcomes. Prehabilitation programs in surgery have shown that the amount of complications is closely related to preoperative physical fitness, nutritional status and psychological well-being. IBD patients often search for self-management strategies to manage their symptoms, however, research focussing on a multimodal intervention approach in parallel to starting new IBD treatment is lacking. Given the potential benefits of intervention programs, limitations of current treatments in terms of improving quality of life and patients' desire for self-management options, we believe that exploring the results of a multimodal intervention program in patients with UC is of high relevance.
Objective/study design: This is a prospective, interventional pilot study to assess the feasibility and optimal timing of a multimodal intervention program in UC patients. Secondly, to demonstrate the effects of a multimodal intervention program on individual patients level and therapy outcomes.
Study population: Patients ≥ 18 years old, with UC. Intervention: Multimodal intervention program including an exercise program, nutritional intervention and psychological evaluation.
Main study parameters/endpoints: This study assesses the feasibility of a multimodal intervention program. Secondary, assesses the effect on:
- Individual patients' level, i.e. physical fitness, nutritional status, mental health, quality of life and work productivity and activity impairment.
- Therapy outcomes, e.g. adherence, number and severity of (S)AEs, corticosteroid use, biochemical and clinical response/remission rates and patient reported outcomes.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
-
Nijmegen, Países Bajos, 6525GA
- Dorien Oomkens
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Age ≥ 18 years old;
- Diagnosis of UC confirmed by clinical, endoscopic, and/or histological evidence prior to screening as per standard criteria;
- Ability of subject to participate fully in all aspects of this project;
- Written informed consent must be obtained and documented.
Exclusion Criteria:
- Suspicion of differential diagnosis of CD, indeterminate colitis, ischemic colitis, radiation colitis, diverticular disease associated with colitis, or microscopic colitis;
- Serious underlying disease other than UC that in the opinion of the investigator may interfere with the subject's ability to participate fully in the study or would compromise subject safety (such as history of malignancies, major neurological disorders, certain orthopedic impairments or any unstable, uncontrolled or severe systemic medical disorder);
- History of alcohol or drug abuse that in the opinion of the investigator may interfere with the subject's ability to comply with the study procedures;
- History of psychiatric disorders that in the opinion of the investigator may interfere with the subject's ability to comply with the study procedures;
- If female, the subject is pregnant or lactating (< 1 year) or intending to become pregnant;
- Immobilized patients who are not able to complete exercise intervention;
- Illiteracy (disability to read and understand Dutch).
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Cuidados de apoyo
- Asignación: N / A
- Modelo Intervencionista: Asignación de un solo grupo
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Patients with ulcerative colitis
Patients participate in multimodal intervention |
Exercise intervention: combined endurance and resistance training three times a week using workout video's which patients can do at home. Advice to exercise at low-intensity for at least 30 minutes per day. Nutritional intervention: Patients are advised to aim for optimal energy and protein intake (by registered dietician) and to avoid red meat, processed foods and sweetened drinks. Aiming for a mainly plant based diet. Psychological intervention: screening for psychological risk factors and if present, patients are referred to a psychologist for psychological support. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Accrural
Periodo de tiempo: 24 weeks
|
The percentage of approached, eligible participants that are included in the study. |
24 weeks
|
|
Attrition
Periodo de tiempo: 24 weeks
|
The percentage of participants who stopped the program prematurely. |
24 weeks
|
|
Adherence to exercise program
Periodo de tiempo: 24 weeks
|
Frequency of followed trainings |
24 weeks
|
|
Adherence to daily exercise goals
Periodo de tiempo: 24 weeks
|
SQUASH questionnaire |
24 weeks
|
|
Patient satisfaction
Periodo de tiempo: 24 weeks
|
Measured using a patient satisfaction questionnaire |
24 weeks
|
|
Safety and adverse events
Periodo de tiempo: 24 weeks
|
Measured by the number of adverse events occurring during the program |
24 weeks
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Oxygen Consumption (VO2 max)
Periodo de tiempo: 1 year
|
Indication of physical fitness |
1 year
|
|
Change in 1 repitition measures
Periodo de tiempo: 1 year
|
Indication of muscle strength |
1 year
|
|
Change in body weight
Periodo de tiempo: 1 year
|
Measured in kilograms |
1 year
|
|
Change in fat-free mass
Periodo de tiempo: 1 year
|
Measured with bioelectrical impedance analysis (BIA) |
1 year
|
|
Change in nutritional status
Periodo de tiempo: 1 year
|
Measured with Patient Generated Subjective Global Assessment (PG-SGA) |
1 year
|
|
Change in mental health
Periodo de tiempo: 1 year
|
Hospital Anxiety and Depression scale (HADS questionnaire) |
1 year
|
|
Change in Work Productivity and Activity Impairment
Periodo de tiempo: 1 year
|
Work Productivity and Activity Impairment Questionnaire (including WPAI-GH) |
1 year
|
|
Change in 36-Item Short Form Health Survey (SF-36) score
Periodo de tiempo: 1 year
|
Quality of life |
1 year
|
|
Change in EuroQoL (EQ-5D-5L) score
Periodo de tiempo: 1 year
|
Quality of life |
1 year
|
|
Change in Inflammatory Bowel Disease Questionnaire score
Periodo de tiempo: 1 year
|
Disease-related quality of life |
1 year
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 114110
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .